intervene with high-pressure balloon angioplasty, cutting balloon angioplasty and balloon expandable stenting to address blood vessel narrowings including pulmonary artery stenoses, aortic coarctation, and systemic venous stenoses. Hybrid interventions wherein surgical and transcatheter techniques are combined in selected patients. Our outcomes for catheter-based therapy are among the best in the country. The MUSC Children’s Hospital has been a leader in the field of interventional pediatric cardiology since the early 1990’s. We are currently co-investigators in several national studies including the MAGIC national intervention database, the Congenital Cardiac Interventional Symposium, and the Angiomax Food and Drug Administration (FDA) phase 1 clinical trial. The Children’s Heart Center recently became the first congenital heart disease program in the US to perform device closure of multiple ventricular septal defects with real-time 3-dimensional echocardiographic guidance. Interventional Cardiologists
Dr. G. Hamilton Baker
Dr. Varsha Bandisode
Dr. Jeremy M. Ringewald |